Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
67%
Autoimmune Disease
67%
Amphibole
62%
Diseases
61%
Asthma
41%
Vermiculite
39%
Melatonin
38%
Burn
32%
Levoglucosan
30%
Occupational Exposure
27%
Respiratory Tract Infection
25%
Prevalence
25%
Pleura Thickening
24%
Systemic Lupus Erythematosus
22%
Exposure Assessment
21%
Placebo
21%
Asbestiform
20%
Inflammatory Arthritis
20%
Rheumatoid Arthritis
20%
Lung Disease
19%
Creatinine
18%
Respiratory Tract Disease
18%
Autoantibodies
18%
Environmental Exposure
16%
Mesothelioma
16%
Asbestos-Related Diseases
15%
Toxic Substance
15%
Lower Respiratory Tract Infection
14%
Systemic Sclerosis
14%
Randomized Controlled Trial
14%
Intervention Study
13%
Alzheimer's Disease
12%
Antinuclear Antibody
12%
Observational Study
12%
Degenerative Disease
10%
Multiple Sclerosis
10%
Temperature Effect
10%
Amyloid Protein
10%
Endotoxin
10%
Tracer
10%
Motor Neuron Disease
10%
Case Fatality Rate
10%
Acanthosis Nigricans
10%
Case-Control Study
10%
Mould
10%
Ornithine Decarboxylase
10%
Mouse Model
10%
Cell Culture
10%
Carboxylyase
10%
Pharmacy Practice
10%
Medicine and Dentistry
Diseases
51%
Amphibole
43%
Asthma
35%
Health Outcomes
34%
Pleura Thickening
24%
Body Mass Index
17%
Diabetes
17%
Melatonin
16%
Cardiovascular System
16%
Autoimmunity
15%
Vermiculite
15%
Health Promotion
14%
Awareness
14%
Cardiovascular Risk
14%
Cross Sectional Study
14%
Household
14%
Prevalence
14%
Cardiovascular Disease
13%
Asbestos Exposure
12%
Computer Assisted Tomography
12%
Public Health
12%
Thermal Burn
10%
Dietary Intake
10%
Lung Function
10%
Cardiac Dysrhythmia
10%
Knee Surgery
10%
Self Concept
10%
Self Report
10%
Diabetes Prevention
10%
Translating (Language)
10%
DNA Methylation
10%
Disease Exacerbation
10%
Triage
10%
Metabolite
10%
Susceptible Population
10%
Particular Matter 2.5
10%
Pediatrics
10%
Lung Function Test
9%
Autoimmune Disease
8%
Lung
8%
Autoantibodies
8%
Natural Killer Cell
8%
Blood Pressure
7%
Systemic Autoimmune Disease
7%
Smoke
7%
Logistic Regression Analysis
7%
Mass-Casualty Incident
6%
Rheumatoid Arthritis
6%
Silo-Filler's Disease
6%
Placebo
6%
Earth and Planetary Sciences
Particular Matter 2.5
100%
United States
80%
Smoke
56%
Fine Particulate Matter
56%
Atmospheric Aerosols
32%
Air Quality
32%
Air Pollution
30%
Indoor Air
28%
Montana
24%
United States of America
23%
Alaska
16%
Confidence Interval
15%
Ambient Air
15%
Emissions
12%
Biomass Burning
10%
Geographical Variation
10%
Hazardous Waste
10%
Combustion Product
10%
Europe
10%
Airspace
10%
Temporal Variation
10%
Atmospherics
10%
Pulmonary Function
10%
Amphibole
10%
Carbon Monoxide
10%
Polycyclic Aromatic Hydrocarbon
10%
Regional Geography
10%
Geography
7%
Geographic Areas
6%
Air Pollutant
5%
